Free Trial

Carmell (NASDAQ:CTCX) Stock Price Down 7.1% - Here's What Happened

Carmell logo with Medical background

Carmell Co. (NASDAQ:CTCX - Get Free Report) dropped 7.1% on Monday . The stock traded as low as $2.71 and last traded at $2.73. Approximately 79,873 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 3,899,615 shares. The stock had previously closed at $2.94.

Carmell Price Performance

The stock has a 50-day moving average price of $1.19 and a two-hundred day moving average price of $0.62.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Carmell stock. Antara Capital LP bought a new stake in shares of Carmell Co. (NASDAQ:CTCX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 100,000 shares of the company's stock, valued at approximately $28,000. Carmell makes up about 0.0% of Antara Capital LP's investment portfolio, making the stock its 10th largest holding. Antara Capital LP owned approximately 0.48% of Carmell as of its most recent SEC filing. 24.22% of the stock is owned by hedge funds and other institutional investors.

About Carmell

(Get Free Report)

Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.

Featured Stories

Should You Invest $1,000 in Carmell Right Now?

Before you consider Carmell, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Carmell wasn't on the list.

While Carmell currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines